David Moadel

David Moadel

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

The Green Energy Boom Favors a Position in FuelCell Energy

The future of FCEL stock could depend on the U.S. government's ability to pass pro-renewable-energy legislation, but that's not a bad thing.

Try a Compelling Charging-Port SPAC with TPG Pace Beneficial Finance

If you're into pre-merger SPAC stocks and you believe in the future of the EV charging-station niche market, then give TPGY stock a try.

Stellar Lumens Could Be the Next Reddit Crowd Beneficiary

Elon Musk and the Redditors may have helped to push Dogecoin to new highs, and there are reasons to believe that Stellar Lumens will be next.

Revenue Growth Makes Supreme Cannabis Stock an Attractive Pot-Sector Play

SPRWF stock is speculative, no doubt, but if you're willing to accept the risks of a low-priced pot stock, then this one's worth considering.

Hold Jaguar Health Stock for SPAC Spin-Off and Covid-19 Connection

JAGX stock holders must weigh the impact of an intriguing European SPAC and a potential treatment option for Covid-19 long-haul patients.